SCHEMBL7377326

SCHEMBL7377326

CC(=O)N[C@@H](Cc1ccc(NC(=O)c2cccc(NC(=N)N)c2)cc1)C(=O)O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 12/20 0.70
ITGB3 P05106 9/20 0.70
ITGA2B P08514 8/20 0.70
ITGAV P06756 8/20 0.70
ITGB5 P18084 6/20 0.70
KMT2A Q03164 2/20 0.48
POLB P06746 1/20 0.48
ITGA4 P13612 6/20 0.48
ITGA2 P17301 1/20 0.46
ITGB7 P26010 1/20 0.46
MMP9 P14780 1/20 0.44
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
PLK4 O00444 1/20 0.44
CHEK1 O14757 1/20 0.44
AURKA O14965 1/20 0.44
CHUK O15111 1/20 0.44
DAPK3 O43293 1/20 0.44
JAK2 O60674 1/20 0.44
ROCK2 O75116 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7377320 1.00 ITGB1 (0.70) ITGB1ITGB3ITGA2BITGAVITGB5
SCHEMBL7378190 0.91 ITGB3 (0.57) ITGB1ITGB3ITGA2BITGAVITGB5
SCHEMBL7378185 0.91 ITGB3 (0.57) ITGB1ITGB3ITGA2BITGAVITGB5
SCHEMBL7376058 0.90 ITGB3 (0.61) ITGB1ITGB3ITGA2BITGAVITGB5
SCHEMBL7376050 0.90 ITGB3 (0.61) ITGB1ITGB3ITGA2BITGAVITGB5
SCHEMBL7374891 0.88 ITGB1 (0.57) ITGB1ITGB3ITGA2BITGAVITGB5
SCHEMBL7378081 0.88 ITGB1 (0.57) ITGB1ITGB3ITGA2BITGAVITGB5
SCHEMBL7382395 0.88 ITGB1 (0.56) ITGB1ITGB3ITGA2BITGAVITGB5
SCHEMBL7382388 0.88 ITGB1 (0.56) ITGB1ITGB3ITGA2BITGAVITGB5
SCHEMBL7377256 0.88 ITGB3 (0.72) ITGB1ITGB3ITGA2BITGAVITGB5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0891325-B1 PARA-SUBSTITUTED PHENYLPROPANOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS SEARLE & CO (US) 2002-02-06 EP claimed
EP-1157985-A1 Para- substituted phenylene derivatives and their use as integrin antagonists G.D. SEARLE & CO. (US) 2001-11-28 EP claimed
EP-0891325-A1 PARA-SUBSTITUTED PHENYLPROPANOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1999-01-20 EP claimed
WO-1997036859-A1 PARA-SUBSTITUTED PHENYLPROPANOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1997-10-09 WO claimed
EP-0891325-B1 PARA-SUBSTITUTED PHENYLPROPANOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS SEARLE & CO (US) 2002-02-06 EP disclosed
EP-1157985-A1 Para- substituted phenylene derivatives and their use as integrin antagonists G.D. SEARLE & CO. (US) 2001-11-28 EP disclosed
US-6251944-B1 (VITRONECTIN RECEPTOR) INTEGRIN ANTAGONIST, USEFUL FOR TREATING ANGIOGENESIS, TUMOR GROWTH, TUMOR METASTASIS, OSTEOPOROSIS AND HUMORAL HYPERCALCEMIA OF MALIGNANCY G. D. SEARLE & COMPANY 2001-06-26 US disclosed
EP-0891325-A1 PARA-SUBSTITUTED PHENYLPROPANOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1999-01-20 EP disclosed
WO-1997036859-A1 PARA-SUBSTITUTED PHENYLPROPANOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1997-10-09 WO disclosed